AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Invested Capital (2012 - 2026)

Updated

AbbVie's Invested Capital came in at $64.89 billion for Q2 2026, down 7.8% from $70.34 billion a year earlier and down 2.1% from the prior quarter.

Analysis

AbbVie (ABBV) Invested Capital (2012 - 2026) Analysis & Trends

For FY2025, AbbVie's Invested Capital was $64.23 billion, down 8.9% from FY2024.

  • Invested Capital carries a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • Going back by year, Invested Capital was $70.51 billion in FY2024 (+1.0%), $69.78 billion in FY2023 (-13.4%), $80.56 billion in FY2022 (-12.6%) and $92.12 billion in FY2021 (-7.1%).
  • The five-year range for quarterly Invested Capital is $64.23 billion (Q4 2025) to $94.3 billion (Q3 2021).
  • Year-over-year, Invested Capital has declined for six consecutive quarters, with an average decline of 6.7% over the last eight quarters.
  • The fastest year-over-year change in Invested Capital over five years came in Q1 2024 (growth of 8.8%), and the weakest in Q1 2023 (a decline of 16.0%).
  • Business Quant data shows ABBV's Invested Capital at $66.25 billion (Q1 2026), $64.23 billion (Q4 2025) and $66.1 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 134.01 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 64.89 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 44.56 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 38.08 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 148.69 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64.89 Bn
Mar 31, 2026 66.25 Bn
Dec 31, 2025 64.23 Bn
Sep 30, 2025 66.10 Bn
Jun 30, 2025 70.34 Bn
Mar 31, 2025 71.35 Bn
Dec 31, 2024 70.51 Bn
Sep 30, 2024 77.15 Bn
Jun 30, 2024 77.46 Bn
Mar 31, 2024 82.05 Bn
Dec 31, 2023 69.78 Bn
Sep 30, 2023 72.88 Bn
Jun 30, 2023 73.91 Bn
Mar 31, 2023 75.40 Bn
Dec 31, 2022 80.56 Bn
Sep 30, 2022 85.63 Bn
Jun 30, 2022 87.62 Bn
Mar 31, 2022 89.79 Bn
Dec 31, 2021 92.12 Bn
Sep 30, 2021 94.30 Bn
API Access

AbbVie Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ABBV&period=max&api_key=YOUR_API_KEY